bioAffinity Technologies Q3 EPS $(0.26) Up From $(1.10) YoY, Sales $298.48K Up From $1.15K YoY
Portfolio Pulse from Benzinga Newsdesk
bioAffinity Technologies (NASDAQ:BIAF) reported a significant improvement in Q3 earnings with a loss of $(0.26) per share compared to a loss of $(1.10) per share in the same quarter last year. Sales also saw a dramatic increase to $298.48K from just $1.15K in the previous year's quarter.
November 14, 2023 | 9:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
bioAffinity Technologies reported a narrower loss per share and a substantial increase in sales in Q3 compared to the same period last year, indicating significant improvement in financial performance.
The substantial improvement in both earnings per share and sales suggests that bioAffinity Technologies is on a positive trajectory, which could lead to increased investor confidence and a potential rise in stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100